Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Canine coronavirus (CCoV) antigens refer to the structural and non-structural proteins of the virus that are recognized by the canine immune system. The most prominent antigen is the Spike (S) protein, which is a large glycoprotein that facilitates viral entry by binding to the host cell receptor, canine aminopeptidase N (CD13) (Decaro & Buonavoglia, 2008). Other essential antigens include the Nucleocapsid (N) protein, which encapsulates the viral RNA, and the Membrane (M) and Envelope (E) proteins, which are vital for viral assembly and structural integrity (Lorusso et al., 2008). These antigens are the primary targets for veterinary vaccines, which utilize inactivated or modified-live virus to stimulate the production of neutralizing antibodies and provide protective immunity (Pratelli, 2008). CCoV is a significant cause of contagious enteric disease in dogs, typically resulting in symptoms like diarrhea, vomiting, and lethargy, particularly in young puppies (Merck Veterinary Manual). While most cases are mild, the antigens are also critical for diagnostic testing, where they are used to detect the presence of the virus or the host's immune response in clinical samples.
Induction of active immunity through the presentation of viral epitopes to B and T lymphocytes, leading to the production of neutralizing antibodies and memory cells (Pratelli, 2008).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Canine coronavirus antigens (CCoV antigens).